Skip to main content
. 2011 Nov 9;2011(11):CD004963. doi: 10.1002/14651858.CD004963.pub3

Hara 2007.

Methods Type of study: RCT.
Participants Number of participants randomised: 52
Losses: 8 of 52 (6 exercise and 2 control) 
 Age: Exercise 84.4 (5.6) Control 85.6 (4.8). 
 Sex: women (n = 35) and men (n = 10). 
 Setting: Japan,
Health of participants: frail
Residential Status: residential care facilities or frail visitors. 
 Inclusion: walk independently or with an aid 
 Exclusion: no specific criteria.
Interventions EXERCISE GROUP (MULTIPLE): Sit to stands, standing up to parallel bars, light weights for seated arm strengthening ‐ low balance challenge 
 CONTROL GROUP: usual activity. 
 Duration and intensity: 2 or 3 times a week for 6 months.‐ duration of exercise not reported, estimated at 30 mins a session 
 Supervisor: not known. 
 Supervision: not clear if in a group or on a one to one basis. 
 Setting: gym in care home.
Outcomes Functional Reach (cm)
Timed Up and Go (clockwise and anticlockwise) (s)
Walking time (s)
Compliance/adherence: not reported.
Adverse events: not reported
Notes Subjects in both groups also attended other group activities in the home.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No randomisation method reported
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Differences between drop outs and completers not reported
Selective reporting (reporting bias) Low risk All outcome measures addressed
Other bias High risk Both groups attended other group activities which may have influenced results as no account of how many or what
Blinding (participant) High risk Not possible
Blinding (assessor) Unclear risk Not reported
Were the treatment and control group comparable at entry? High risk Only reported on age, weight and height (no differences) but although measured did not report on balance and strength
Was the surveillance active, and of clinically appropriate duration (i.e. at least 3 months post intervention)? High risk Only immediately post intervention data, no follow‐up data reported.